Seqens Seqens

X

Find Radio Compass News for Brinzolamide

PharmaCompass
API SUPPLIERS
API Suppliers

API Suppliers

US DMFs Filed

US DMFs Filed

CEP/COS Certifications

CEP/COS Certifications

0

JDMFs Filed

JDMFs Filed

Other Certificates

Other Certificates

Other Suppliers

Other Suppliers

API REF. PRICE (USD / KG)
INTERMEDIATES
DOSSIERS // FDF
USA (Orange Book)

USA (Orange Book)

Europe

Europe

Canada

Canada

0

Australia

Australia

0

South Africa

South Africa

0

Uploaded Dossiers

Uploaded Dossiers

GLOBAL SALES (USD Million)

U.S. Medicaid

Annual Reports

0

EXCIPIENTS
PATENTS & EXCLUSIVITIES

USFDA Orange Book Patents

USFDA Exclusivities

DIGITAL CONTENT

Blog #PharmaFlow

0

News

REF STANDARD

EDQM

0

USP

JP

0

Other Listed Suppliers

SERVICES

0

https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=212137

FDA
29 Nov 2023

https://www.prnewswire.com/news-releases/padagis-announces-the-launch-of-brinzolamide-ophthalmic-suspension-with-cgt-exclusivity-301956510.html

PR NEWSWIRE
13 Oct 2023

https://www.pharmacompass.com/pdf/news/fda-confirms-paragraph-iv-patent-litigation-for-simbrinza-brinzolamide-and-brimonidine-tartrate-26922.pdf

FDA
22 Sep 2022

https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-january-26-2022-1643358623.pdf

FDA
26 Jan 2022

https://economictimes.indiatimes.com/industry/healthcare/biotech/pharmaceuticals/teva-launches-indoco-remedies-developed-generic-drug-in-us/articleshow/81409963.cms

ECONOMIC TIMES
10 Mar 2021

https://www.businesswire.com/news/home/20210308005815/en/Teva-Announces-Launch-of-First-Generic-Version-of-AZOPT%C2%AE-brinzolamide-ophthalmic-suspension-1-used-to-treat-high-pressure-inside-the-eye-in-the-United-States

BUSINESSWIRE
08 Mar 2021

https://www.otsuka.co.jp/en/company/newsreleases/2020/20200616_1.html

PRESS RELEASE
16 Jun 2020
Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty
Post Enquiry
POST ENQUIRY